The flavivirus precursor membrane-envelope protein complex: structure and maturation.

PubWeight™: 3.26‹?› | Rank: Top 1%

🔗 View Article (PMID 18369147)

Published in Science on March 28, 2008

Authors

Long Li1, Shee-Mei Lok, I-Mei Yu, Ying Zhang, Richard J Kuhn, Jue Chen, Michael G Rossmann

Author Affiliations

1: Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.

Articles citing this

(truncated to the top 100)

Cross-reacting antibodies enhance dengue virus infection in humans. Science (2010) 4.63

Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol (2009) 3.19

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res (2012) 2.46

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A (2012) 2.42

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34

Structural changes of envelope proteins during alphavirus fusion. Nature (2010) 2.32

Molecular targets for flavivirus drug discovery. Antiviral Res (2008) 2.32

Cryo-EM structure of the mature dengue virus at 3.5-Å resolution. Nat Struct Mol Biol (2012) 2.27

Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14

The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog (2010) 2.03

Temperature dependent conformational change of dengue virus. Curr Opin Virol (2015) 1.98

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J (2009) 1.85

Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol (2008) 1.83

Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A (2013) 1.75

Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature (2015) 1.72

A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog (2011) 1.70

Yellow fever: a reemerging threat. Clin Lab Med (2010) 1.69

Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol (2009) 1.65

Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol (2009) 1.60

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol (2010) 1.59

Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57

Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology (2011) 1.48

Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol (2009) 1.43

Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol (2010) 1.41

Viral membrane fusion. Virology (2015) 1.40

Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog (2010) 1.35

Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog (2012) 1.31

Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms. J Virol (2011) 1.24

Role of conserved histidine residues in the low-pH dependence of the Semliki Forest virus fusion protein. J Virol (2009) 1.24

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J Virol (2013) 1.22

Virus maturation. Annu Rev Biophys (2012) 1.20

Cell entry of enveloped viruses. Curr Opin Virol (2011) 1.18

Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol (2012) 1.15

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. PLoS Negl Trop Dis (2012) 1.14

Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS One (2009) 1.13

A stable prefusion intermediate of the alphavirus fusion protein reveals critical features of class II membrane fusion. Cell Host Microbe (2008) 1.11

New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol (2015) 1.10

Analysis of Dengue Virus Genetic Diversity during Human and Mosquito Infection Reveals Genetic Constraints. PLoS Negl Trop Dis (2015) 1.09

Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res (2008) 1.09

An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection. J Virol (2013) 1.07

In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol (2010) 1.07

Immature and mature dengue serotype 1 virus structures provide insight into the maturation process. J Virol (2013) 1.05

A physical interaction network of dengue virus and human proteins. Mol Cell Proteomics (2011) 1.03

Flaviviruses: braking the entering. Curr Opin Virol (2013) 1.02

In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog (2010) 1.02

Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses. J Biol Chem (2011) 1.02

Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus. J Virol (2013) 1.01

Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol (2014) 1.00

Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect (2010) 1.00

Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog (2014) 0.98

prM-antibody renders immature West Nile virus infectious in vivo. J Gen Virol (2011) 0.98

Flavivirus RNA cap methyltransferase: structure, function, and inhibition. Front Biol (Beijing) (2010) 0.97

Atomic-level functional model of dengue virus Envelope protein infectivity. Proc Natl Acad Sci U S A (2013) 0.97

Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog (2013) 0.97

Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers. J Virol (2014) 0.95

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein. PLoS Pathog (2013) 0.94

Subunits fold at position-dependent rates during maturation of a eukaryotic RNA virus. Proc Natl Acad Sci U S A (2010) 0.94

Principles of virus structural organization. Adv Exp Med Biol (2012) 0.94

Focus on flaviviruses: current and future drug targets. Future Med Chem (2009) 0.94

Powerful sequence similarity search methods and in-depth manual analyses can identify remote homologs in many apparently "orphan" viral proteins. J Virol (2013) 0.93

A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions. Arch Biochem Biophys (2009) 0.93

Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines (2012) 0.93

Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. Virology (2010) 0.93

Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother (2013) 0.93

The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases. J Virol (2011) 0.92

A fusion-loop antibody enhances the infectious properties of immature flavivirus particles. J Virol (2011) 0.92

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J Gen Virol (2011) 0.91

Biological and historical overview of Zika virus. World J Virol (2017) 0.91

The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation. J Biol Chem (2012) 0.89

Zika Virus: Immunity and Vaccine Development. Cell (2016) 0.89

A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus. J Virol (2012) 0.89

Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex. J Biomed Biotechnol (2012) 0.89

Sequential conformational rearrangements in flavivirus membrane fusion. Elife (2014) 0.88

Illustrating and homology modeling the proteins of the Zika virus. F1000Res (2016) 0.86

The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states. J Virol (2013) 0.86

A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins. Nat Commun (2014) 0.86

Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol Biol (2011) 0.86

The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry. Virology (2010) 0.86

Geometric considerations in virus capsid size specificity, auxiliary requirements, and buckling. Proc Natl Acad Sci U S A (2009) 0.85

Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. PLoS One (2014) 0.84

A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. PLoS Pathog (2014) 0.84

A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection. Prog Mol Biol Transl Sci (2014) 0.83

Recent advances in understanding dengue. F1000Res (2016) 0.82

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Vaccine (2008) 0.82

Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology (2011) 0.82

The flavivirus protease as a target for drug discovery. Virol Sin (2013) 0.81

Molecular Characterization of a Novel Bovine Viral Diarrhea Virus Isolate SD-15. PLoS One (2016) 0.80

Herpesvirus gB: A Finely Tuned Fusion Machine. Viruses (2015) 0.80

C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One (2012) 0.80

Structures of viral membrane proteins by high-resolution cryoEM. Curr Opin Virol (2014) 0.80

Chaperone fusion proteins aid entropy-driven maturation of class II viral fusion proteins. Trends Microbiol (2013) 0.80

A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds. PLoS One (2013) 0.80

Structural differences observed in arboviruses of the alphavirus and flavivirus genera. Adv Virol (2014) 0.80

Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol (2017) 0.80

The role of E3 in pH protection during alphavirus assembly and exit. J Virol (2013) 0.79

Viral precursor polyproteins: keys of regulation from replication to maturation. Curr Opin Virol (2013) 0.79

The alphavirus E3 glycoprotein functions in a clade-specific manner. J Virol (2012) 0.79

Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus. Virol J (2012) 0.79

Prediction of protein-protein interactions in dengue virus coat proteins guided by low resolution cryoEM structures. BMC Struct Biol (2010) 0.79

Articles by these authors

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12

HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69

Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev (2008) 5.97

Enhanced nitrogen deposition over China. Nature (2013) 5.49

A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02

Outcome of the first electron microscopy validation task force meeting. Structure (2012) 4.35

Crystal structure of a catalytic intermediate of the maltose transporter. Nature (2007) 4.20

Developmental fluoride neurotoxicity: a systematic review and meta-analysis. Environ Health Perspect (2012) 4.15

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science (2011) 4.13

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05

Nitrogen deposition and its ecological impact in China: an overview. Environ Pollut (2010) 4.03

ATP-binding cassette transporters in bacteria. Annu Rev Biochem (2004) 3.88

Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86

Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res (2006) 3.83

One-year health care costs associated with delirium in the elderly population. Arch Intern Med (2008) 3.82

Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66

Structures of immature flavivirus particles. EMBO J (2003) 3.62

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res (2009) 3.57

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest (2006) 3.49

Structure of West Nile virus. Science (2003) 3.48

V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature (2006) 3.45

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology (2010) 3.37

Structure of the cell-puncturing device of bacteriophage T4. Nature (2002) 3.32

Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host. Cell (2004) 3.31

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun (2004) 3.29

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol (2008) 3.27

Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol (2007) 3.13

Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09

The structure of the phage T4 DNA packaging motor suggests a mechanism dependent on electrostatic forces. Cell (2008) 3.07

The structure and evolution of the major capsid protein of a large, lipid-containing DNA virus. Proc Natl Acad Sci U S A (2002) 3.07

Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A (2010) 2.97

Crystal structure of a Rad51 filament. Nat Struct Mol Biol (2004) 2.83

The tail structure of bacteriophage T4 and its mechanism of contraction. Nat Struct Mol Biol (2005) 2.82

Placement of the structural proteins in Sindbis virus. J Virol (2002) 2.81

Conservation of the capsid structure in tailed dsDNA bacteriophages: the pseudoatomic structure of phi29. Mol Cell (2005) 2.80

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med (2005) 2.69

Proposed diagnostic criteria for internet addiction. Addiction (2010) 2.68

Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res (2009) 2.64

A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment method. J Am Geriatr Soc (2005) 2.63

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension (2007) 2.62

Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62

Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis (2011) 2.59

Activity-independent homeostasis in rhythmically active neurons. Neuron (2003) 2.57

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res (2009) 2.54

Structural and functional similarities between the capsid proteins of bacteriophages T4 and HK97 point to a common ancestry. Proc Natl Acad Sci U S A (2005) 2.53

Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc (2003) 2.53

Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev (2010) 2.53

Giant Marseillevirus highlights the role of amoebae as a melting pot in emergence of chimeric microorganisms. Proc Natl Acad Sci U S A (2009) 2.52

Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis (2012) 2.49

CutDB: a proteolytic event database. Nucleic Acids Res (2006) 2.41

Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells (2013) 2.40

Chromatin remodelers Isw1 and Chd1 maintain chromatin structure during transcription by preventing histone exchange. Nat Struct Mol Biol (2012) 2.37

Survival prediction of gastric cancer by a seven-microRNA signature. Gut (2009) 2.37

Structural insights into ABC transporter mechanism. Curr Opin Struct Biol (2008) 2.33

Structural changes of envelope proteins during alphavirus fusion. Nature (2010) 2.32

Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32

Molecular architecture of the prolate head of bacteriophage T4. Proc Natl Acad Sci U S A (2004) 2.24

Picornavirus-receptor interactions. Trends Microbiol (2002) 2.23

Alternating access in maltose transporter mediated by rigid-body rotations. Mol Cell (2009) 2.20

SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood (2008) 2.19

Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science (2014) 2.16

Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Nature (2012) 2.16

Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16

Flexible DNA bending in HU-DNA cocrystal structures. EMBO J (2003) 2.15

Retracted MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem (2007) 2.14

Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol (2007) 2.14

Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust (2008) 2.11

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res (2012) 2.10

Lack of association of ADH1C genotype with breast cancer susceptibility in Caucasian population: a pooled analysis of case-control studies. Breast (2012) 2.08

Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell (2006) 2.08

Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int (2005) 2.07

Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem (2005) 2.07

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation (2010) 2.07

Three-dimensional structure of bacteriophage T4 baseplate. Nat Struct Biol (2003) 2.05

The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc Natl Acad Sci U S A (2004) 2.05

MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05

Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci U S A (2005) 2.03

Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One (2008) 2.01

miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res (2011) 2.00

Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy. J Crit Care (2007) 2.00